Safety and efficacy of left bundle branch area pacing compared with right ventricular pacing in patients with bradyarrhythmia and conduction system disorders: a systematic review and meta-analysis

Georgios Leventopoulos, Christoforos K. Travlos, Konstantinos N. Aronis, Virginia Anagnostopoulou, Panagiotis Patrinos, Angeliki Papageorgiou, Angelos Perperis, Chris P Gale, Periklis DavlourosmedRxiv 2023 · DOI

This systematic review and meta-analysis, published in early 2023, evaluates a significant shift in cardiac pacing technology: moving from "brute force" muscle stimulation to "physiological" conduction system pacing.

TL;DR

Left Bundle Branch Area Pacing (LBBAP) significantly outperforms traditional Right Ventricular Pacing (RVP) by reducing heart failure hospitalizations by 67% and all-cause mortality by 48%. By tapping into the heart's natural electrical "wiring," LBBAP maintains mechanical synchrony and improves clinical outcomes without increasing procedural complications.

What Problem Does This Paper Address?

For decades, Right Ventricular Pacing (RVP) has been the standard treatment for bradyarrhythmia (slow heart rate). While effective at keeping the heart beating, RVP is electrically inefficient. It stimulates the heart muscle directly, causing an unnatural, staggered contraction known as electromechanical dyssynchrony.

Think of it like trying to power a house by plugging a generator into a random wall outlet instead of the main breaker box; the electricity eventually gets everywhere, but the timing is off, and the system is stressed. In the heart, this "off-timing" can lead to pacing-induced cardiomyopathy, atrial fibrillation (AF), and heart failure. The authors sought to determine if a newer technique, LBBAP—which targets the heart's specialized conduction system—could solve these issues safely.

Methods

The authors conducted a systematic review and meta-analysis following PRISMA guidelines. They aggregated data from 25 studies (4 randomized controlled trials and 21 observational studies) comparing LBBAP to RVP.

Key methodological features included:

  • Search Strategy: Comprehensive search of Medline, Embase, and PubMed through November 2022.
  • Statistical Modeling: Used both random-effects and fixed-effects models to calculate Risk Ratios (RR) for dichotomous outcomes (like death or hospitalization) and Weighted Mean Differences (WMD) for continuous variables (like QRS duration).
  • Quality Assessment: Evaluated using the Cochrane Risk of Bias 2 tool for RCTs and the Newcastle-Ottawa scale for observational studies.

Datasets

The "dataset" for this meta-analysis consisted of 25 clinical trials involving a total of 4,250 patients (2,127 receiving LBBAP and 2,123 receiving RVP). The average follow-up period was approximately 11 months.

Key Insights and Ideas

  • Restoring the "Natural" Rhythm: The most striking insight is that LBBAP effectively "corrects" the electrical delay. It resulted in a significantly shorter QRS duration (~32ms shorter than RVP), meaning the electrical signal travels through the heart much faster and more naturally.
  • Synchrony Over Raw Power: While LBBAP showed a slight improvement in Left Ventricular Ejection Fraction (LVEF), the authors suggest the real clinical benefit comes from mechanical synchrony. RVP causes the heart walls to contract out of sync, often leading to mitral valve leakage (regurgitation). LBBAP prevents this by ensuring the ventricles squeeze together.
  • Safety Parity: A major hurdle for new surgical techniques is the "learning curve" and complication rate. This study found that LBBAP is just as safe as the decades-old RVP standard, with no significant difference in total lead-related complications (1.67% vs 1.54%).

Key Results

The quantitative advantages of LBBAP over RVP were substantial:

  • Heart Failure Hospitalization (HFH): 67% lower risk (RR: 0.33).
  • All-Cause Mortality: 48% lower risk (RR: 0.52).
  • Atrial Fibrillation (AF) Occurrence: 57% lower risk (RR: 0.43).
  • Electrical Efficiency: Shorter QRS duration (WMD: -32.20 msec) and better intraventricular mechanical synchrony (SMD: -1.77).
  • Pacing Parameters: LBBAP achieved higher R-wave amplitudes (better signal sensing) while maintaining similar pacing thresholds to RVP.

Limitations and Future Work

The authors highlight several caveats:

  1. Observational Bias: The majority of the included studies (21 out of 25) were observational, which can introduce selection bias.
  2. Short Follow-up: With a mean follow-up of only 11 months, the long-term durability and safety of LBBAP leads (which are screwed deeper into the heart tissue than RVP leads) remain unproven over decades.
  3. Need for Large-Scale RCTs: While the results are promising, the medical community awaits the results of ongoing large-scale randomized trials like LEAP-Block and PROTECT-SYNC to definitively establish LBBAP as a first-line therapy in clinical guidelines.

Summary updated

Abstract

Abstract Background Right Ventricular Pacing (RVP) may have detrimental effects in ventricular function. Left Bundle Branch Area Pacing (LBBAP) is a new pacing strategy that appears to have better results. The aim of this systematic review and meta-analysis is to compare the safety and efficacy of LBBAP vs RVP in patients with bradyarrhythmia and conduction system disorders. Methods Medline, Embase and Pubmed databases were searched for studies comparing LBBAP with RVP. Outcomes were all-cause mortality, atrial fibrillation (AF) occurrence, heart failure hospitalizations (HFH) and complications. QRS duration, mechanical synchrony and LVEF changes were also assessed. Pairwise meta-analysis was conducted using random and fixed effects models. Results Twenty-five trials with 4250 patients (2127 LBBAP) were included in the analysis. LBBAP was associated with lower risk for HFH (RR:0.33, CI 95%:0.21 to 0.50; p <0.001), all-cause mortality (RR:0.52 CI 95%:0.34 to 0.80; p =0.003), and AF occurrence (RR:0.43 CI 95%:0.27 to 0.68; p <0.001) than RVP. Lead related complications were not different between the two groups ( p= 0.780). QRSd was shorter in the LBBAP group at follow-up (WMD: -32.20 msec, CI 95%: -40.70 to -23.71; p <0.001) and LBBAP achieved better intraventricular mechanical synchrony than RVP (SMD: -1.77, CI 95%: -2.45 to -1.09; p <0.001). LBBAP had similar pacing thresholds ( p =0.860) and higher R wave amplitudes ( p =0.009) than RVP. Conclusions LBBAP has better clinical outcomes, preserves ventricular electrical and mechanical synchrony and has excellent pacing parameters, with no difference in complications compared to RVP. Clinical Perspective What is known Left bundle branch area pacing (LBBAP) is a method of conduction system pacing with higher procedural success rate and less limitations compared to His bundle pacing (HBP). Right ventricular pacing (RVP) causes electromechanical dyssynchrony, which may result in left ventricular systolic dysfunction in some patients. What the study adds We examined in a systematic review and meta-analysis whether there was a difference in clinical outcomes, electromechanical synchronization, and safety between LBBAP and RVP in patients with bradyarrhythmia and conduction system disorders.
BibTeX
@misc{leventopoulos2023safety,
  author = {Georgios Leventopoulos and Christoforos K. Travlos and Konstantinos N. Aronis and Virginia Anagnostopoulou and Panagiotis Patrinos and Angeliki Papageorgiou and Angelos Perperis and Chris P Gale and Periklis Davlouros},
  title = {{Safety and efficacy of left bundle branch area pacing compared with right ventricular pacing in patients with bradyarrhythmia and conduction system disorders: a systematic review and meta-analysis}},
  year = {2023},
  doi = {10.1101/2023.02.09.23285675},
  howpublished = {medRxiv},
}
Figure